title: Evaluating rivaroxaban for nonvalvular atrial fibrillation--regulatory considerations.
authors: Department of Biostatistics, University of Washington, Seattle, USA.
authors: Thomas R
authors: TR
authors: Fleming
authors: Scott S
authors: SS
authors: Emerson
mesh_terms: D026683:Advisory Committees; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban